Insider trade

CEO sold ~$5.54M of ALHC shares in the open market

Traded Jul 10, 2026 · Filed Jul 15, 2026

Why it stands out

The boss of Alignment Healthcare sold $5.54M of Alignment Healthcare shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEOIndirect holding$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$5,540,363

Shares × reported transaction price

Timing vs results

71 days after results of Apr 30, 2026, 20 days before results of Jul 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−0.8%	−1.0%	+0.2%
30 days	−33.3%	+2.9%	−36.1%

Past results only. Not a forecast.

Date of Rule 10b5-1 plan adoption: 11/21/2025
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Scheduled in advance8w ago

3mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance3mo ago